<DOC>
	<DOCNO>NCT01637545</DOCNO>
	<brief_summary>Postoperative nausea vomiting ( PONV ) one common distress complication anaesthesia surgery , may lead serious postoperative complication This prospective , randomize study design evaluate best injection time get prophylactic anti-emetic efficacy ramosetron , newly develop 5-HT ( 3 ) antagonist patient undergo facial bone surgery .</brief_summary>
	<brief_title>Evaluation Safety Efficacy Nasea ( R ) /Ramosetron Inj . Patients Undergoing Facial Bone Fracture Operations</brief_title>
	<detailed_description>1 . Participants - 100 patient undergoing facial bone surgery go randomly allocate one 3 group 2 . Randomization - G1 ( n=33 ) - Ramosetron 0.3mg i.v . begin surgery - G2 ( n=33 ) - Ramosetron 0.3mg i.v . end surgery move Recovery room - G3 ( n=33 ) - No medication regular antiemetic i.v . patient want 3 . The primary endpoint - incidence nausea vomit 24 h surgery 0-6h , 6-12 h 12-24 h 4 . The secondary endpoint - severity nausea , need rescue medication - patient satisfaction efficacy</detailed_description>
	<mesh_term>Fractures , Bone</mesh_term>
	<mesh_term>Facies</mesh_term>
	<mesh_term>Skull Fractures</mesh_term>
	<mesh_term>Ramosetron</mesh_term>
	<criteria>Patient sign inform consent form study patient consider surgical candidate facial bone fracture Patient nausea/vomiting episode</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2015</verification_date>
	<keyword>facial bone</keyword>
	<keyword>Post operative nasea vomit</keyword>
	<keyword>fracture</keyword>
	<keyword>reduction</keyword>
</DOC>